Literature DB >> 18182578

NFAT but not NF-kappaB is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells.

Erik Ullerås1, Mats Karlberg, Christine Möller Westerberg, Jessica Alfredsson, Steve Gerondakis, Andreas Strasser, Gunnar Nilsson.   

Abstract

FcepsilonRI-activation-induced survival of mast cells is dependent on the expression and function of the prosurvival protein A1. The expression of A1 in lymphocytes and monocytes has previously been described to be transcriptionally regulated by NF-kappaB. Here we demonstrate that the expression of A1 in mast cells is not dependent on NF-kappaB but that NFAT plays a crucial role. FcepsilonRI-induced A1 expression was not affected in mast cells overexpressing an IkappaB-alpha super-repressor or cells lacking NF-kappaB subunits RelA, c-Rel, or c-Rel plus NF-kappaB1 p50. In contrast, inhibition of calcineurin and NFAT by cyclosporin A abrogated the expression of A1 in mast cells on FcepsilonRI-activation but had no effect on lipopolysaccharide-induced expression of A1 in J774A.1 monocytic cells. Cyclosporin A also inhibited luciferase expression in an A1 promoter reporter assay. A putative NFAT binding site in the A1 promoter showed inducible protein binding after FcepsilonRI crosslinking or treatment with ionomycin as detected in a band shift assay or chromatin immunoprecipitation. The binding protein was identified as NFAT1. Finally, mast cells expressing constitutively active NFAT1 exhibit increased expression of A1 after FcepsilonRI-stimulation. These results indicate that, in FcepsilonRI stimulated mast cells, A1 is transcriptionally regulated by NFAT1 but not by NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182578      PMCID: PMC2265451          DOI: 10.1182/blood-2006-10-053371

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  51 in total

1.  Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI.

Authors:  Jiro Kitaura; Jinming Song; Mindy Tsai; Koichi Asai; Mari Maeda-Yamamoto; Attila Mocsai; Yuko Kawakami; Fu-Tong Liu; Clifford A Lowell; B George Barisas; Stephen J Galli; Toshiaki Kawakami
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

2.  Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival.

Authors:  Jiro Kitaura; Wenbin Xiao; Mari Maeda-Yamamoto; Yuko Kawakami; Clifford A Lowell; Toshiaki Kawakami
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

Review 3.  Mast-cell responses to pathogens.

Authors:  Jean S Marshall
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

Review 4.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

5.  Morphologic mast cell cycles.

Authors:  A M Dvorak; R P Schleimer; L M Lichtenstein
Journal:  Cell Immunol       Date:  1987-03       Impact factor: 4.868

6.  Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.

Authors:  M Triggiani; R Cirillo; L M Lichtenstein; G Marone
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

7.  Degranulation and regranulation of human mast cells. An electron microscopic study of the whealing reaction in urticaria pigmentosa.

Authors:  T Kobayasi; G Asboe-Hansen
Journal:  Acta Derm Venereol       Date:  1969       Impact factor: 4.437

8.  Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells.

Authors:  C Pedersen; H Permin; P Stahl Skov; S Norn; M Svenson; H Mosbech; K Bendtzen
Journal:  Allergy       Date:  1985-02       Impact factor: 13.146

9.  Cyclosporine and FK506 inhibition of murine mast cell cytokine production.

Authors:  S M Hatfield; N W Roehm
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

10.  A DNase I-hypersensitive site in the second intron of the murine IL-4 gene defines a mast cell-specific enhancer.

Authors:  G Henkel; D L Weiss; R McCoy; T Deloughery; D Tara; M A Brown
Journal:  J Immunol       Date:  1992-11-15       Impact factor: 5.422

View more
  13 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

Review 2.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

3.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  The transcription factor Zeb2 regulates signaling in mast cells.

Authors:  Emilia Alina Barbu; Juan Zhang; Elsa H Berenstein; Jacqueline R Groves; Lauren M Parks; Reuben P Siraganian
Journal:  J Immunol       Date:  2012-05-04       Impact factor: 5.422

Review 5.  A1/Bfl-1 in leukocyte development and cell death.

Authors:  Eleonora Ottina; Denise Tischner; Marco J Herold; Andreas Villunger
Journal:  Exp Cell Res       Date:  2012-02-04       Impact factor: 3.905

6.  Calcineurin/NFAT signalling inhibits myeloid haematopoiesis.

Authors:  Jan Fric; Clarice X F Lim; Esther G L Koh; Benjamin Hofmann; Jinmiao Chen; Hock Soon Tay; Siti Aminah Bte Mohammad Isa; Alessandra Mortellaro; Christiane Ruedl; Paola Ricciardi-Castagnoli
Journal:  EMBO Mol Med       Date:  2012-02-07       Impact factor: 12.137

7.  Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin-NFAT pathway.

Authors:  P E Cippà; A K Kraus; M T Lindenmeyer; J Chen; A Guimezanes; P D Bardwell; T Wekerle; R P Wüthrich; T Fehr
Journal:  Cell Death Dis       Date:  2012-04-19       Impact factor: 8.469

8.  Characterisation of a novel A1-specific monoclonal antibody.

Authors:  M J Lang; M S Brennan; L A O'Reilly; E Ottina; P E Czabotar; E Whitlock; W D Fairlie; L Tai; A Strasser; M J Herold
Journal:  Cell Death Dis       Date:  2014-12-04       Impact factor: 8.469

Review 9.  Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player.

Authors:  G P Mognol; F R G Carneiro; B K Robbs; D V Faget; J P B Viola
Journal:  Cell Death Dis       Date:  2016-04-21       Impact factor: 8.469

Review 10.  Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.

Authors:  Yu-wen Lv; Jing Wang; Ling Sun; Jian-min Zhang; Lei Cao; Yue-yue Ding; Ye Chen; Ji-juan Dou; Jie Huang; Yi-fei Tang; Wen-tao Wu; Wei-rong Cui; Hai-tao Lv
Journal:  Comput Math Methods Med       Date:  2013-03-06       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.